Sign In
Buy ESPR
$3.14
+0 (+0%)
At Close: Jun 03, 2026
Esperion Therapeutics (ESPR) Moves 6.5% Higher: Will This Strength Last?
09:47am, Wednesday, 12'th Oct 2022
Esperion Therapeutics (ESPR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further pric
Strength Seen in Esperion Therapeutics (ESPR): Can Its 5.7% Jump Turn into More Strength?
04:31am, Friday, 16'th Sep 2022
Esperion Therapeutics (ESPR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the
Esperion Therapeutics: Positive Update On CLEAR Outcomes Trial Offsets Mixed Q2 Earnings
10:18pm, Monday, 08'th Aug 2022
Esperion Therapeutics reported its Q2 earnings that revealed a beat on revenue, but a miss on EPS. However, the company announced that it has hit 100% MACE-4 accumulation. The company's mixed earnings
Esperion (ESPR) Q2 Earnings and Revenues Miss Estimates
12:47pm, Wednesday, 03'rd Aug 2022
Esperion Therapeutics (ESPR) reports dismal second-quarter results, missing estimates for earnings and sales. However, shares rose on the back of ESPR's progress with its cardiovascular outcome study.
Esperion Therapeutics, Inc. (ESPR) CEO Sheldon Koenig on Q2 2022 Results - Earnings Call Transcript
01:40pm, Tuesday, 02'nd Aug 2022
Start Time: 08:00 January 1, 0000 8:44 AM ET Esperion Therapeutics, Inc. (NASDAQ:ESPR ) Q2 2022 Earnings Conference Call August 02, 2022, 08:00 AM ET Company Participants Sheldon Koenig - President an
Esperion Therapeutics (ESPR) Reports Q2 Loss, Misses Revenue Estimates
09:50am, Tuesday, 02'nd Aug 2022
Esperion Therapeutics (ESPR) delivered earnings and revenue surprises of -10.53% and 2.62%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Esperion to Report Second Quarter 2022 Financial Results August 2, 2022
08:00am, Tuesday, 12'th Jul 2022
ANN ARBOR, Mich., July 12, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR), today announced it will report second quarter 2022 financial results before the open of the U.S. financial markets on Tuesd
Esperion Therapeutics (ESPR) Down 15.1% Since Last Earnings Report: Can It Rebound?
12:48pm, Thursday, 02'nd Jun 2022
Esperion Therapeutics (ESPR) reported earnings 30 days ago. What's next for the stock?
Esperion to Participate in Upcoming H.C. Wainwright Global Investment Conference
08:00am, Tuesday, 17'th May 2022
ANN ARBOR, Mich., May 17, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR), today announced that President and Chief Executive Officer, Sheldon Koenig, will participate in a fireside chat at the upcom
Esperion Therapeutics: 2021 Labors Paying Off In 2022
12:03am, Saturday, 07'th May 2022
Esperion Therapeutics reported their Q1 earnings that revealed a beat on EPS and revenue. The company reported $13.4M in U.S. product revenue for Q1, which was up around 109% year-over-year.
Esperion (ESPR) Q1 Earnings Beat on Robust Demand for Drugs
12:02pm, Wednesday, 04'th May 2022
Esperion Therapeutics (ESPR) reports solid first-quarter results, beating estimates for earnings and sales. Cost-savings programs boost margins.
Esperion Therapeutics, Inc. (ESPR) CEO Sheldon Koenig on Q1 2022 Results - Earnings Call Transcript
02:08pm, Tuesday, 03'rd May 2022
Esperion Therapeutics, Inc. (NASDAQ:ESPR ) Q1 2022 Earnings Conference Call May 3, 2022 8:00 AM ET Company Participants Tiffany Aldrich - Senior Manager, Corporate Communications Sheldon Koenig - Pres
Esperion Therapeutics (ESPR) Reports Q1 Loss, Tops Revenue Estimates
09:47am, Tuesday, 03'rd May 2022
Esperion Therapeutics (ESPR) delivered earnings and revenue surprises of 3.12% and 21.29%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Drug/Biotech Stocks Q1 Earnings Due on May 3: PFE, BIIB & More
05:18pm, Monday, 02'nd May 2022
Let's look at the five biotech/pharma companies, slated to release quarterly results on May 3.
Esperion to Report First Quarter 2022 Financial Results May 3, 2022
07:00am, Tuesday, 19'th Apr 2022
ANN ARBOR, Mich., April 19, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR), today announced it will report first quarter 2022 financial results before the open of the U.S. financial markets on Tuesd
